Zoledronic Acid

CAS 118072-93-8 19 current records 5 historicalSmall Molecule

Who holds supplier records for Zoledronic Acid? 19 organisations hold a current record for Zoledronic Acid: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), Argentina (2), Taiwan (1), Netherlands (1) and 3 other countries (3); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Zoledronic Acid: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/zoledronic-acid

Reading the evidence

  • 19 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 12 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Zoledronic Acid expires 5 Aug 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (19)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Zoledronic Acid. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Zoledronic Acid sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Zoledronic Acid, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. LinyiCN
CEP 2021-177 - Rev 01
Zoledronic acid monohydrate
Oct 2026Inspected Apr 2025
Germany
EMCURE PHARMACEUTICALS LIMITED PuneIN
CEP 2020-205 - Rev 04
Zoledronic acid monohydrate
Jul 2026—
HETERO LABS LIMITED HyderabadIN
CEP 2021-181 - Rev 01
Zoledronic acid monohydrate
Jul 2026—
SCINOPHARM TAIWAN LTD. ShanhuaTW
CEP 2019-281 - Rev 02
Zoledronic acid monohydrate
Jan 2026—
JUBILANT BIOSYS LIMITED NanjangudIN
CEP 2019-349 - Rev 02
Zoledronic acid monohydrate
Sept 2025—
TAPI NL B.V. AmsterdamNL
CEP 2020-018 - Rev 02
Zoledronic acid monohydrate
Feb 2025—
HIKMA PHARMACEUTICALS LLC AmmanJO
CEP 2023-275 - Rev 00
Zoledronic acid monohydrate
Dec 2024—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2021-269 - Rev 01
Zoledronic acid monohydrate
Oct 2024—
ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdańskiPL
CEP 2018-191 - Rev 03
Zoledronic acid monohydrate
Jul 2024Inspected Jul 2026
Poland
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2019-314 - Rev 01
Zoledronic acid monohydrate
May 2024—
USV PRIVATE LIMITED MumbaiIN
R0-CEP 2022-203 - Rev 00
Zoledronic acid monohydrate
Feb 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Zoledronic Acid are no longer active. These show a past filing, not current supply.

Show all 5 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (26 listed products contain Zoledronic Acid). The latest listed patent expires 5 Aug 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Zoledronic acid is a bisphosphonate drug used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. It works by inhibiting the activity of osteoclasts, cells that break down bone tissue.

Chemical identity

IUPAC name
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;hydrate
Canonical SMILES
C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
InChIKey
FUXFIVRTGHOMSO-UHFFFAOYSA-N
Synonyms
Zometa API; Reclast API, aclasta, ak-156, cgp 42446, cgp-42446, cgp-42446a, reclast, zoladrona acid mylan, zoledronate hydrate, zoledronic, zoledronic acid accord, zoledronic acid actavis

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Bisphosphonate
Chemical structure
Diphosphonates

Therapeutic areas

OncologyOsteoporosisMetabolic Bone Diseases

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Zoledronic Acid?

19 organisations hold an active US FDA Type II Drug Master File or a CEP for Zoledronic Acid: Shandong New Time Pharmaceutical Co Ltd, Dr. Reddy's Laboratories Ltd. (India), Emcure Pharmaceuticals Limited (India), Hetero Labs Limited (India), HIKMA PHARMACEUTICALS LLC, JUBILANT BIOSYS LTD (India), SCINOPHARM TAIWAN LTD (Taiwan) and SHILPA PHARMA LIFESCIENCES LTD (India), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Zoledronic Acid Drug Master Files are active?

Shandong New Time Pharmaceutical Co Ltd (DMF 35934, 23847), Dr. Reddy's Laboratories Ltd. (DMF 21344, 21389), Emcure Pharmaceuticals Limited (DMF 23768), Hetero Labs Limited (DMF 24666), HIKMA PHARMACEUTICALS LLC (DMF 23036), JUBILANT BIOSYS LTD (DMF 20052), SCINOPHARM TAIWAN LTD (DMF 22688) and SHILPA PHARMA LIFESCIENCES LTD (DMF 25905) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Zoledronic Acid records mean?

5 organisations have only inactive Type II DMFs for Zoledronic Acid. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Zoledronic Acid have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Zoledronic Acid on the EDQM register, including SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. Linyi (CN), EMCURE PHARMACEUTICALS LIMITED Pune (IN), HETERO LABS LIMITED Hyderabad (IN), SCINOPHARM TAIWAN LTD. Shanhua (TW), JUBILANT BIOSYS LIMITED Nanjangud (IN) and TAPI NL B.V. Amsterdam (NL) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Zoledronic Acid?

Yes. The latest patent listed for an approved US product containing Zoledronic Acid expires 5 Aug 2028, across 26 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Zoledronic Acid supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Zoledronic Acid?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.